Intelerad Recalls IntelePACS Software Over Cybersecurity Vulnerabilities
Intelerad Medical Systems is recalling IntelePACS software due to security issues that could cause data loss or system lockouts.
Intelerad Medical Systems Incorporated is recalling 560 IntelePACS software platforms due to cybersecurity and software defect risks.
A cybersecurity vulnerability in the software could allow an unauthorized user to gain control of an administrator session, modify or delete study and image data, or lock legitimate users out of the system. In addition, a separate software issue can cause image data to be unintendedly deleted from integrated external archives.
The recalled software was distributed to facilities across 41 U.S. states and Washington, D.C., as well as internationally in Australia, Canada, Ireland, New Zealand, South Africa, and the United Kingdom. The U.S. Food and Drug Administration has classified this as a Class II recall.
What to do
- Contact Intelerad Medical Systems Incorporated for guidance and software updates.
- Stop using affected software platforms if advised by the manufacturer or system administrators until security fixes are applied.
- Report any adverse events or technical problems related to the software to the FDA.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | Z-0357-2027 |
| Date | 2026-11-11 |
| Company | INTELERAD MEDICAL SYSTEMS INCORPORATED, Montreal |
| Severity | Class II |
| Quantity | 560 software platforms |
| Where sold | US: AL FL CO MI CA TX CT AZ NJ IL NC SC MO NH WA KY WY DC NV IN PA AK OR AR KS TN MN MD IA WI HI NY OH VA WV NM GA LA NE UT WA OUS: Australia , Canada, Ireland, New Zealand, South Africa, United Kingdom |
| Lot codes / identifiers | HIBCC:B228INTELEPACS0/Affected versions: PACS-4-3-4-R20 PACS-4-9-1-R80 PACS-4-12-1-R81 through R90 PACS-4-14-1-R46 through R137 PACS-4-16-1-R50 through R137 PACS-4-17-1-R23 through R117 PACS-4-18-1-R31 through R91 PACS-5-1-1-R17 through R102 PACS-5-2-1-R36 through R93 PACS-5-3-1-R26 through R128 PACS-5-4-1-R15 through R101 PACS-5-5-1-R7 through R89 PACS-5-6-1-R12 through R81 PACS-5-7-1-R2 through R61 PACS-5-8-1-R2 through R42 PACS-5-9-1-R8 through R19 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.